Tan Tien-En, Tan Donald Tiang Hwee
Corneal and External Eye Disease Department, Singapore National Eye Centre, Singapore.
Cornea Service, Eye & Retina Surgeons, Camden Medical Centre, Singapore.
Cornea. 2019 Apr;38(4):413-418. doi: 10.1097/ICO.0000000000001847.
To describe 4 cases of cytomegalovirus (CMV) corneal endotheliitis occurring after Descemet membrane endothelial keratoplasty (DMEK).
This is a retrospective, interventional case series. Case records of 4 patients (one eye each) diagnosed with CMV corneal endotheliitis after DMEK were reviewed retrospectively. Presenting clinical features, treatment, and outcomes were examined.
Patients' age ranged from 68 to 77 years. Three patients underwent DMEK for failed corneal grafts and 1 for pseudophakic bullous keratopathy. Time from DMEK to presentation ranged from 5 to 15 weeks. Presenting features included corneal edema, pigmented keratic precipitates, mild anterior chamber inflammation, and raised intraocular pressure. Two cases were initially misdiagnosed as graft rejection and treated with corticosteroids. Both worsened, and delayed diagnoses of CMV corneal endotheliitis were made. The two other cases were diagnosed correctly at initial presentation. All cases were confirmed by anterior chamber paracentesis and polymerase chain reaction testing for CMV. All cases were treated initially with topical ganciclovir gel and oral valganciclovir. Three cases showed clinical resolution. Final corrected visual acuity ranged from 20/25 to 20/40. One case failed to respond to topical ganciclovir gel, oral valganciclovir, and intravenous ganciclovir and foscarnet. This patient declined further systemic treatment and was maintained on topical ganciclovir only but subsequently showed spontaneous resolution 3 months later.
CMV corneal endotheliitis may occur after DMEK and can closely mimic graft rejection. Polymerase chain reaction testing of aqueous humor is advised for suspect cases. A high index of suspicion is important for prompt diagnosis and initiation of appropriate antiviral treatment.
描述4例在Descemet膜内皮角膜移植术(DMEK)后发生的巨细胞病毒(CMV)角膜内皮炎病例。
这是一项回顾性干预病例系列研究。对4例(每例1只眼)在DMEK后被诊断为CMV角膜内皮炎的患者的病例记录进行回顾性分析。检查了呈现的临床特征、治疗方法及结果。
患者年龄在68至77岁之间。3例患者因角膜移植失败接受DMEK,1例因人工晶状体眼大泡性角膜病变接受该手术。从DMEK到出现症状的时间为5至15周。呈现的特征包括角膜水肿、色素性角膜后沉着物、轻度前房炎症和眼压升高。2例最初被误诊为移植排斥反应并接受了皮质类固醇治疗。二者病情均恶化,随后才做出CMV角膜内皮炎的延迟诊断。另外2例在初次就诊时被正确诊断。所有病例均通过前房穿刺及CMV聚合酶链反应检测得以确诊。所有病例最初均接受局部更昔洛韦凝胶和口服缬更昔洛韦治疗。3例显示临床症状消退。最终矫正视力范围为20/25至20/40。1例对局部更昔洛韦凝胶、口服缬更昔洛韦以及静脉注射更昔洛韦和膦甲酸钠均无反应。该患者拒绝进一步的全身治疗,仅维持局部使用更昔洛韦,但随后在3个月后出现自发缓解。
CMV角膜内皮炎可能在DMEK后发生,且可与移植排斥反应极为相似。对于可疑病例,建议进行房水聚合酶链反应检测。高度的怀疑指数对于及时诊断和启动适当的抗病毒治疗很重要。